References
- Godwin JD. Carcinoid tumors. An analysis of 2837 cases. Cancer 1975; 36: 560–9
- Bukowski R M, Johnson K G, Peterson R F, et al. A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. Cancer 1987; 60: 2891–5
- Öberg K, Funa K, Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with midgut carcinoid tumors and the carcinoid syndrome. N Engl J Med 1983; 309: 129–33
- Öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Cancer Treat Rep 1986; 70: 1297–304
- Öberg K, Aim G, Magnusson A, et al. Treatment of malignant carcinoid tumors with recombinant interferon alpha-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. J Natl Cancer Inst 1989; 81: 531–5
- Smith D B, Scarffe J H, Wagstaff J, Johnston RJ. Phase II trial of rDNA alpha 2b interferon in patients with malignant carcinoid tumor. Cancer Treat Rep 1987; 71: 1265–6
- Nobin A, Lindblom A, Månsson B, Sundberg M. Interferon treatment in patients with malignant carcinoids. Acta Oncol 1989; 28: 445–9
- Moertel C G, Rubin J, Kvols LK. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 1989; 7: 865–8